Long Noncoding RNA MEG3 is Downregulated in Cervical Cancer and Affects Cell Proliferation and Apoptosis by Regulating MiR-21

Overview

Journal Cancer Biol Ther

Specialties Oncology
Pharmacology

Date 2015 Nov 18

PMID 26574780

Citations 146

Authors

Jun Zhang

Tingting Yao

Yaxian Wang

Jin Yu

Yunyun Liu

Zhongqiu Lin

Affiliations

Soon will be listed here.

Abstract

Recent research has found that long noncoding RNAs (lncRNAs) were involved in various human cancers. However, the role of these lncRNAs in cervical cancer remains unexplored. Therefore, we aimed to investigate the biological function of maternally expressed gene 3 (MEG3), a cancer-related lncRNA, and its underlying mechanism in cervical cancer. In this study, MEG3 expression of 108 patients' cervical cancer tissues and adjacent normal tissues was detected by quantitative real-time PCR analysis (qRT-PCR), and the functional effect of MEG3 was determined in vitro assays. We observed that MEG3 was downregulated in cervical cancer tissues, compared to the adjacent normal tissues, and was negatively related with FIGO stages, tumor size, lymphatic metastasis, HR-HPV infection and the expression of homo sapiens microRNA-21 (miR-21). Furthermore, we focused on the function and molecular mechanism of MEG3, finding that overexpression of MEG3 reduced the level of miR-21-5p expression, causing inhibition of proliferation and increased apoptosis in cervical cancer cells. In summary, our findings indicate that MEG3 function as a tumor suppressor by regulating miR-21-5p, resulting in the inhibition of tumor growth in cervical cancer. As a result, this study improves our understanding of the function of MEG3 in cervical cancer and will help to provide new potential target sites for cervical cancer treatment.

Citing Articles

Combined replacement of lnc-MEG3 and miR-155 elicit tumor suppression in multiple myeloma.

El-Khazragy N, Abdelrahman S, Darwish A, Hemida E Epigenomics. 2025; 17(3):167-177.

PMID: 39815805 PMC: 11816889. DOI: 10.1080/17501911.2025.2453413.

New sights on long non-coding RNAs in glioblastoma: A review of molecular mechanism.

Bagheri-Mohammadi S, Karamivandishi A, Mahdavi S, Siahposht-Khachaki A Heliyon. 2024; 10(21):e39744.

PMID: 39553554 PMC: 11564028. DOI: 10.1016/j.heliyon.2024.e39744.

Deciphering the nexus between long non-coding RNAs and endoplasmic reticulum stress in hepatocellular carcinoma: biomarker discovery and therapeutic horizons.

Goyal H, Parwani S, Kaur J Cell Death Discov. 2024; 10(1):451.

PMID: 39448589 PMC: 11502918. DOI: 10.1038/s41420-024-02200-2.

Therapeutic combinations of exosomes alongside cancer stem cells (CSCs) and of CSC-derived exosomes (CSCEXs) in cancer therapy.

Zabeti Touchaei A, Norollahi S, Najafizadeh A, Babaei K, Bakhshalipour E, Vahidi S Cancer Cell Int. 2024; 24(1):334.

PMID: 39369258 PMC: 11453077. DOI: 10.1186/s12935-024-03514-y.

Enhancing outcome prediction of concurrent chemoradiation treatment in patients with locally advanced cervical cancer through plasma extracellular vesicle proteomics.

Leetanaporn K, Chiangjong W, Roytrakul S, Molika P, Janmunee N, Atjimakul T Heliyon. 2024; 10(16):e36374.

PMID: 39262965 PMC: 11388600. DOI: 10.1016/j.heliyon.2024.e36374.

References

Khalil A, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D . Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009; 106(28):11667-72. PMC: 2704857. DOI: 10.1073/pnas.0904715106. View

Wilusz J, Sunwoo H, Spector D . Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009; 23(13):1494-504. PMC: 3152381. DOI: 10.1101/gad.1800909. View

Faghihi M, Zhang M, Huang J, Modarresi F, van der Brug M, Nalls M . Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol. 2010; 11(5):R56. PMC: 2898074. DOI: 10.1186/gb-2010-11-5-r56. View

Lujambio A, Portela A, Liz J, Melo S, Rossi S, Spizzo R . CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer. Oncogene. 2010; 29(48):6390-401. PMC: 3007676. DOI: 10.1038/onc.2010.361. View

Collins L . The RNA infrastructure: an introduction to ncRNA networks. Adv Exp Med Biol. 2011; 722:1-19. DOI: 10.1007/978-1-4614-0332-6_1. View

Forouzanfar M, Foreman K, Delossantos A, Lozano R, Lopez A, Murray C . Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011; 378(9801):1461-84. DOI: 10.1016/S0140-6736(11)61351-2. View

Yao T, Lin Z . MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20. Biochim Biophys Acta. 2011; 1822(2):248-60. DOI: 10.1016/j.bbadis.2011.09.018. View

Keniry A, Oxley D, Monnier P, Kyba M, Dandolo L, Smits G . The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol. 2012; 14(7):659-65. PMC: 3389517. DOI: 10.1038/ncb2521. View

Zhao Y, Wang J, Chen X, Wu Y, Wu Q . Values of three different preoperative regimens in comprehensive treatment for young patients with stage Ib2 cervical cancer. Asian Pac J Cancer Prev. 2012; 13(4):1487-9. DOI: 10.7314/apjcp.2012.13.4.1487. View

10.

Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao L . Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell. 2013; 25(1):69-80. DOI: 10.1016/j.devcel.2013.03.002. View

11.

Leucci E, Patella F, Waage J, Holmstrom K, Lindow M, Porse B . microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Sci Rep. 2013; 3:2535. PMC: 3756333. DOI: 10.1038/srep02535. View

12.

Zhang Z, Zhu Z, Watabe K, Zhang X, Bai C, Xu M . Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ. 2013; 20(11):1558-68. PMC: 3792431. DOI: 10.1038/cdd.2013.110. View

13.

Lu K, Li W, Liu X, Sun M, Zhang M, Wu W . Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer. 2013; 13:461. PMC: 3851462. DOI: 10.1186/1471-2407-13-461. View

14.

Tewari K, Sill M, Long 3rd H, Penson R, Huang H, Ramondetta L . Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014; 370(8):734-43. PMC: 4010094. DOI: 10.1056/NEJMoa1309748. View

15.

Sun M, Xia R, Jin F, Xu T, Liu Z, De W . Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol. 2013; 35(2):1065-73. DOI: 10.1007/s13277-013-1142-z. View

16.

Wu X, Wang X, Wu W, Hu Y, Li M, Ding Q . MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway. Cancer Biol Ther. 2014; 15(6):806-14. PMC: 4049796. DOI: 10.4161/cbt.28584. View

17.

Wang P, Liu Y, Yao Y, Li Z, Li Z, Ma J . Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21. Cell Signal. 2014; 27(2):275-82. DOI: 10.1016/j.cellsig.2014.11.011. View

18.

Shishodia G, Verma G, Srivastava Y, Mehrotra R, Das B, Chandra Bharti A . Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein. BMC Cancer. 2014; 14:996. PMC: 4364636. DOI: 10.1186/1471-2407-14-996. View

19.

Liu S, Song L, Zhang L, Zeng S, Gao F . miR-21 modulates resistance of HR-HPV positive cervical cancer cells to radiation through targeting LATS1. Biochem Biophys Res Commun. 2015; 459(4):679-85. DOI: 10.1016/j.bbrc.2015.03.004. View

20.

Qin R, Chen Z, Ding Y, Hao J, Hu J, Guo F . Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis. Neoplasma. 2013; 60(5):486-92. DOI: 10.4149/neo_2013_063. View